121 related articles for article (PubMed ID: 19115640)
1. [Progress in studies on effects of extracellular matrix in occurrence of proliferative vitreoretinopathy].
Wang LH; Li GL
Zhonghua Yan Ke Za Zhi; 2008 Aug; 44(8):759-63. PubMed ID: 19115640
[TBL] [Abstract][Full Text] [Related]
2. Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC).
Hiscott P; Hagan S; Heathcote L; Sheridan CM; Groenewald CP; Grierson I; Wong D; Paraoan L
Eye (Lond); 2002 Jul; 16(4):393-403. PubMed ID: 12101446
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.
Kon CH; Occleston NL; Charteris D; Daniels J; Aylward GW; Khaw PT
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1524-9. PubMed ID: 9660504
[TBL] [Abstract][Full Text] [Related]
4. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
Webster L; Chignell AH; Limb GA
Exp Eye Res; 1999 Jan; 68(1):91-8. PubMed ID: 9986746
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation.
Padgett LC; Lui GM; Werb Z; LaVail MM
Exp Eye Res; 1997 Jun; 64(6):927-38. PubMed ID: 9301473
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid suppresses the adhesion and migration of human retinal pigment epithelial cells.
Du YH; Hirooka K; Miyamoto O; Bao YQ; Zhang B; An JB; Ma JX
Exp Eye Res; 2013 Apr; 109():22-30. PubMed ID: 23428742
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function.
Smith MF; McIntush EW; Ricke WA; Kojima FN; Smith GW
J Reprod Fertil Suppl; 1999; 54():367-81. PubMed ID: 10692869
[TBL] [Abstract][Full Text] [Related]
8. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
[TBL] [Abstract][Full Text] [Related]
9. Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: insights from a computational model.
Karagiannis ED; Popel AS
J Theor Biol; 2006 Jan; 238(1):124-45. PubMed ID: 16005020
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
11. All-trans retinoic acid remodels extracellular matrix and suppresses laminin-enhanced contractility of cultured human retinal pigment epithelial cells.
Chang YC; Kao YH; Hu DN; Tsai LY; Wu WC
Exp Eye Res; 2009 May; 88(5):900-9. PubMed ID: 19094985
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy.
Salzmann J; Limb GA; Khaw PT; Gregor ZJ; Webster L; Chignell AH; Charteris DG
Br J Ophthalmol; 2000 Oct; 84(10):1091-6. PubMed ID: 11004090
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
14. Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells.
Mousa SA; Lorelli W; Campochiaro PA
J Cell Biochem; 1999 Jul; 74(1):135-43. PubMed ID: 10381270
[TBL] [Abstract][Full Text] [Related]
15. Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells.
Eichler W; Friedrichs U; Thies A; Tratz C; Wiedemann P
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2767-73. PubMed ID: 12147614
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study.
Hirano H; Tsuji M; Kizaki T; Sashikata T; Yoshi Y; Okada Y; Mori H
Med Electron Microsc; 2002 Mar; 35(1):16-23. PubMed ID: 12111403
[TBL] [Abstract][Full Text] [Related]
17. Galectin-1 influences migration of retinal pigment epithelial cells.
Alge CS; Priglinger SG; Kook D; Schmid H; Haritoglou C; Welge-Lussen U; Kampik A
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):415-26. PubMed ID: 16384992
[TBL] [Abstract][Full Text] [Related]
18. Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration.
Leu ST; Batni S; Radeke MJ; Johnson LV; Anderson DH; Clegg DO
Exp Eye Res; 2002 Jan; 74(1):141-54. PubMed ID: 11878827
[TBL] [Abstract][Full Text] [Related]
19. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
20. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
Janssens S; Lijnen HR
Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
